LncRNA SNHG8 Serves as an Oncogene in Breast Cancer Through miR-634/ZBTB20 Axis

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.2159031912902
   PubMed Web of Science ®Google Scholar
• Konner M. Progress in the treatment of breast cancer. N Engl J Med. 2020;382:e4.
   PubMed Web of Science ®Google Scholar
• Rozeboom B, Dey N, De P. ER+ metastatic breast cancer: past, present, and a prescription for an apoptosis-targeted future. Am J Cancer Res. 2019;9(12):2821–2831.31911865
   PubMed Web of Science ®Google Scholar
• Solinas C, Aiello M, Migliori E, Willard-Gallo K, Emens LA. Breast cancer vaccines: heeding the lessons of the past to guide a path forward. Cancer Treat Rev. 2020;84:101947. doi:10.1016/j.ctrv.2019.10194731926403
   PubMed Web of Science ®Google Scholar
• Banik K, Ranaware AM, Choudhary H, et al. Piceatannol: a natural stilbene for the prevention and treatment of cancer. Pharmacol Res. 2020;153:104635. doi:10.1016/j.phrs.2020.10463531926274
   PubMed Web of Science ®Google Scholar
• Akhade VS, Pal D, Kanduri C. Long noncoding RNA: genome organization and mechanism of action. Adv Exp Med Biol. 2017;1008:47–74.28815536
   PubMed Web of Science ®Google Scholar
• Luo N, Zhang K, Li X, Hu Y. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA. J Cell Biochem. 2020;121(10):4176–4187. doi:10.1002/jcb.2957231922280
   PubMed Web of Science ®Google Scholar
• Guo S, Jian L, Tao K, Chen C, Yu H, Liu S. Novel breast-specific long non-coding RNA LINC00993 acts as a tumor suppressor in triple-negative breast cancer. Front Oncol. 2019;9:1325. doi:10.3389/fonc.2019.0132531921620
   PubMed Web of Science ®Google Scholar
• Li J, Li Z, Zheng W, et al. LncRNA-ATB: an indispensable cancer-related long noncoding RNA. Cell Prolif. 2017;50.
   Web of Science ®Google Scholar
• Ferre F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction. Brief Bioinform. 2016;17(1):106–116. doi:10.1093/bib/bbv03126041786
   PubMed Web of Science ®Google Scholar
• Liu Y, Sharma S, Watabe K. Roles of lncRNA in breast cancer. Front Biosci (Schol Ed). 2015;7(1):94–108. doi:10.2741/s42725961689
   PubMedGoogle Scholar
• Zhang P, Li S, Chen Z, Lu Y, Zhang H. LncRNA SNHG8 promotes proliferation and invasion of gastric cancer cells by targeting the miR-491/PDGFRA axis. Hum Cell. 2020;33(1):123–130. doi:10.1007/s13577-019-00290-031620977
   PubMed Web of Science ®Google Scholar
• Song Y, Zou L, Li J, Shen ZP, Cai YL, Wu XD. LncRNA SNHG8 promotes the development and chemo-resistance of pancreatic adenocarcinoma. Eur Rev Med Pharmacol Sci. 2018;22(23):8161–8168. doi:10.26355/eurrev_201812_1650830556854
   PubMed Web of Science ®Google Scholar
• Dong J, Teng F, Guo W, Yang J, Ding G, Fu Z. lncRNA SNHG8 promotes the tumorigenesis and metastasis by sponging miR-149-5p and predicts tumor recurrence in hepatocellular carcinoma. Cell Physiol Biochem. 2018;51(5):2262–2274. doi:10.1159/00049587130537734
   PubMedGoogle Scholar
• Wei W, Liu Y, Lu Y, Yang B, Tang L. LncRNA XIST promotes pancreatic cancer proliferation through miR-133a/EGFR. J Cell Biochem. 2017;118(10):3349–3358. doi:10.1002/jcb.2598828295543
   PubMed Web of Science ®Google Scholar
• Samson M, Porter N, Orekoya O, et al. Progestin and breast cancer risk: a systematic review. Breast Cancer Res Treat. 2016;155(1):3–12. doi:10.1007/s10549-015-3663-126700034
   PubMed Web of Science ®Google Scholar
• Castaneda SA, Strasser J. updates in the treatment of breast cancer with radiotherapy. Surg Oncol Clin N Am. 2017;26(3):371–382. doi:10.1016/j.soc.2017.01.01328576177
   PubMed Web of Science ®Google Scholar
• Zhang L, Yan X, Yu S, et al. LINC00365-SCGB2A1 axis inhibits the viability of breast cancer through targeting NF-kappaB signaling. Oncol Lett. 2020;19(1):753–762. doi:10.3892/ol.2019.1116631897191
   PubMed Web of Science ®Google Scholar
• Zhu Q, Li Y, Dong X, Yang Y, Wang H, Guo S. Linc-OIP5 loss regulates migration and invasion in MDA-MB-231 breast cancer cells by inhibiting YAP1/JAG1 signaling. Oncol Lett. 2020;19(1):103–112. doi:10.3892/ol.2019.1107131897120
   PubMed Web of Science ®Google Scholar
• Qiu P, Dou Y, Ma LZ, Tang XX, Liu XL, Chen JW. Long non-coding RNA TTN-AS1 promotes the metastasis in breast cancer by epigenetically activating DGCR8. Eur Rev Med Pharmacol Sci. 2019;23(24):10835–10841. doi:10.26355/eurrev_201912_1978731858552
   PubMed Web of Science ®Google Scholar
• Xia W, Liu Y, Cheng T, Xu T, Dong M, Hu X. Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1. J Exp Clin Cancer Res. 2020;39(1):18. doi:10.1186/s13046-020-1520-531952549
   PubMed Web of Science ®Google Scholar
• Dong HT, Liu Q, Zhao T, et al. Long non-coding RNA LOXL1-AS1 drives breast cancer invasion and metastasis by antagonizing mir-708-5p expression and activity. Mol Ther Nucleic Acids. 2020;19:696–705. doi:10.1016/j.omtn.2019.12.01631945728
   PubMedGoogle Scholar
• Yang CH, Zhang XY, Zhou LN, et al. LncRNA SNHG8 participates in the development of endometrial carcinoma through regulating c-MET expression by miR-152. Eur Rev Med Pharmacol Sci. 2018;22(6):1629–1637. doi:10.26355/eurrev_201803_1469829630089
   PubMed Web of Science ®Google Scholar
• Liu J, Yang C, Gu Y, et al. Knockdown of the lncRNA SNHG8 inhibits cell growth in Epstein-Barr virus-associated gastric carcinoma. Cell Mol Biol Lett. 2018;23(1):17. doi:10.1186/s11658-018-0070-829736176
   PubMed Web of Science ®Google Scholar
• Chen C, Zhang Z, Li J, Sun Y. SNHG8 is identified as a key regulator in non-small-cell lung cancer progression sponging to miR-542-3p by targeting CCND1/CDK6. Onco Targets Ther. 2018;11:6081–6090. doi:10.2147/OTT.S17048230275712
   PubMed Web of Science ®Google Scholar
• Jiang C, Chen X, Alattar M, Wei J, Liu H. MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer. Cancer Gene Ther. 2015;22(6):291–301. doi:10.1038/cgt.2015.1925998522
   PubMed Web of Science ®Google Scholar
• Mulrane L, McGee SF, Gallagher WM, O’Connor DP. miRNA dysregulation in breast cancer. Cancer Res. 2013;73(22):6554–6562. doi:10.1158/0008-5472.CAN-13-184124204025
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Inoue J, Kawano T, Tanimoto K, Kozaki K, Inazawa J. mir-634 activates the mitochondrial apoptosis pathway and enhances chemotherapy-induced cytotoxicity. Cancer Res. 2015;75(18):3890–3901. doi:10.1158/0008-5472.CAN-15-025726216549
   PubMed Web of Science ®Google Scholar
• van Jaarsveld MT, van Kuijk PF, Boersma AW, et al. miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway. Mol Cancer. 2015;14(1):196. doi:10.1186/s12943-015-0464-426576679
   PubMed Web of Science ®Google Scholar
• Tan Z, Zhao J, Jiang Y. MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway. Cancer Med. 2018;7(3):913–921. doi:10.1002/cam4.135129473317
   PubMed Web of Science ®Google Scholar
• Peng X, Cao P, He D, et al. MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo. Int J Clin Exp Pathol. 2014;7(10):6784–6791.25400759
   PubMed Web of Science ®Google Scholar
• Xu D, Yu J, Gao G, Lu G, Zhang Y, Ma P. LncRNA DANCR functions as a competing endogenous RNA to regulate RAB1A expression by sponging miR-634 in glioma. Biosci Rep. 2018;38.
   Web of Science ®Google Scholar
• Shao B, He L. Hsa_circ_0001742 promotes tongue squamous cell carcinoma progression via modulating miR-634 expression. Biochem Biophys Res Commun. 2019;513(1):135–140. doi:10.1016/j.bbrc.2019.03.12230944081
   PubMed Web of Science ®Google Scholar
• Guo J, Zhang CD, An JX, et al. Expression of miR-634 in gastric carcinoma and its effects on proliferation, migration, and invasion of gastric cancer cells. Cancer Med. 2018;7(3):776–787. doi:10.1002/cam4.120429464926
   PubMed Web of Science ®Google Scholar
• Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80. doi:10.1016/S0140-6736(19)30956-031178151
   PubMed Web of Science ®Google Scholar
• Zhao JG, Ren KM, Tang J. Zinc finger protein ZBTB20 promotes cell proliferation in non-small cell lung cancer through repression of FoxO1. FEBS Lett. 2014;588(24):4536–4542. doi:10.1016/j.febslet.2014.10.00525311537
   PubMed Web of Science ®Google Scholar